Summary:
A randomized, 6-week, double-blind, placebo-controlled, flexible-dose, parallel-group study of Lurasidone adjunctive to Lithium or Divalproex for the treatment of bipolar I depression.
Qualified Participants Must:
• Be 18 to 75 years of age
•
Be diagnosed with bipolar I disorder
•
Currently be taking either lithium or depakote (divalproex)
•
Currently be depressed
•
Be in good physical health
•
Have a body mass index (BMI) between 18 and 40
Qualified Participants May Receive:
Doctors visits, study medications, study evaluations, and compensation for time and travel.